Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Merck
Federal Trade Commission
Julphar
Queensland Health

Generated: April 19, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ibrutinib

« Back to Dashboard

ibrutinib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-070-28 28 CAPSULE in 1 BOTTLE, PLASTIC (57962-070-28)
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-140-09 90 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-09)
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-140-12 120 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-12)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Army
Merck
UBS
Accenture
Moodys